[ Price : $8.95]
FDA grants Merus a breakthrough therapy designation for petosemtamab for treating certain patients with recurrent or metastatic he...[ Price : $8.95]
FDA issues a warning for healthcare providers and consumers not to use Cue Healths Covid-19 tests due to the increased risk of fal...[ Price : $8.95]
FDA issues Eugia Pharma Specialties (an Aurobindo subsidiary) a seven-item Form-483 following a 5/3-concluded inspection at its st...[ Price : $8.95]
FDA accepts for priority review a Regeneron Pharmaceuticals and Sanofi supplemental BLA for Dupixent (dupilumab) as an add-on main...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for GlaxoSmithKlines Jemperli (...[ Price : $8.95]
FDA tells Moderna that it needs a couple more weeks to complete the review of its BLA for mRNA-1345, the companys investigational ...[ Price : $8.95]
Megadyne recalls and removes from the market all Mega Soft Pediatric Patient Return Electrodes after receiving reports of patient ...[ Price : $8.95]
FDA gives SN Bioscience a fast-track designation for its nanoparticle anticancer drug SNB-101 for treating small cell lung cancer.